HRA000474
Title:
Potent Neutralizing Antibodies against SARS-CoV-2 identified by High-throughout Single-Cell Sequencing of Convalescent Patients' B Cells
Release date:
2020-12-13
Description:
Neutralizing antibodies, which could effectively block virus entry into host cells, are urgently needed for intervention against COVID-19. Using high-throughout single-cell RNA sequencing, we identified hundreds of potent neutralizing antibodies from sixty convalescent patients' B cells.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
COVID-19
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC_BIOPIC_xielab_antidody
Contact person:
Zhou Junxia
Email:
datacontact@biopic.pku.edu.cn
Description:
DAC for the controlled access of the neutralizing antibodies against SARS-CoV-2.
Individuals & samples
Submitter:   Xie Xiaoliang / datacontact@biopic.pku.edu.cn
Organization:   Peking University
Submission date:   2020-12-03
Requests:   -